BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity

Kai Chen, Yixuan Zhao, Kentaro Takeda +1

The US Food and Drug Administration (FDA) launched Project Optimus and issued guidance to reform dose-finding and selection trials, shifting the paradigm from identifying the maxim…